Ultragenyx Pharmaceutical

RARE

NASDAQHealth Care

Income Statement

Total Revenue$560M

Gross Profit$483M

Operating Income$-536M

EBITDA$-531M

EBIT$-567M

Pre-tax Income$-605.23M

Net Income$-569M

Cash Equivalent$229.39M

Total Debt$920.3M

Book Value$297.13M

Book Value Per Share3.40

Return on Equity (ROE)-222.95%

Return on Assets (ROA)-37.86%

Return on Invested Capital (ROI)-222.95%

Net Profit Margin-101.60%

Current Ratio2.37

Quick Ratio2.15

Long-Term Debt / Equitynull